Transforming PAH Management with PHORA: Empowering Physicians for Better Patient CareThe Pulmonary Hypertension Outcomes Risk Assessment (PHORA): a PAH risk stratification tool. Pulmonary Arterial Hypertension (PAH) demands precise risk stratification for effective patient management. Clinical decision support tools can help inform treatment decisions made by physicians and other healthcare providers, usually at the point of care.
The Need Current methods for assisting clinical decisions relating to PAH lack the sophistication required to predict patient outcomes accurately, leading to suboptimal treatment decisions and higher healthcare costs. A comprehensive tool is needed to empower physicians with timely insights, enabling targeted interventions and referrals.
The Technology: Researchers at The Ohio State University have developed the Pulmonary Hypertension Outcomes Risk Assessment (PHORA), providing a cutting-edge risk stratification tool for PAH. PHORA offers an intuitive user interface, providing a seamless experience, which enables physicians to effortlessly navigate and interpret patient data. The tool can be integrated with HER systems, ensuring a unified patient profile and can be accessed on a mobile phone or tablet, allowing physicians to make informed decisions anytime, anywhere. Benefits/Advantages: Revolutionizing PAH Management
Benefits/Advantages: Elevating PAH Patient Care
Patent applications pending |
Tech IDT2022-226 CollegeLicensing ManagerHampton, Andrew InventorsCategories |